Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05167695 · ClinicalTrials.gov registry record · NA
Maintaining Behavior Change: An Evaluation of a Habit-based Sleep Health Intervention
A NA study of Circadian Dysregulation, sponsored by University of California, Berkeley.
- Active
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT05167695: Active NA study of Circadian Dysregulation, sponsored by University of California, Berkeley.
NCT05167695 is a NA study of Circadian Dysregulation that is active but no longer recruiting, run by University of California, Berkeley. The registered enrollment target is 160 participants, above the 55-participant average among 10 other Circadian Dysregulation trials with a reported enrollment target (191% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05167695, a NA study of Circadian Dysregulation, is active but no longer recruiting, sponsored by University of California, Berkeley.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will test a sleep-health intervention that leverages the science on habit formation. It will evaluate if adding a text messaging intervention improves habit formation. The participants will be 18-30 years old.
Primary Outcome
16-item; 0-4 scale. Scores can range from 0 to 64 (Higher score means more automaticity in utilization).
Conditions Studied
Interventions
- BEHAVIORAL Habit-based Sleep Health Intervention
- BEHAVIORAL Text messaging intervention
Study Locations (1)
California
- University of California - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-05-04 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What the registry record for NCT05167695 still lists
NCT05167695 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 55-participant average among 10 other Circadian Dysregulation trials with a reported enrollment target (191% higher).
The record links to 1 condition, with Circadian Dysregulation appearing as the primary indexed condition, and to 2 interventions - of which Habit-based Sleep Health Intervention is the first listed.
NCT05167695 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05167695 about?
NCT05167695 is a clinical study titled "Maintaining Behavior Change: An Evaluation of a Habit-based Sleep Health Intervention". The study will test a sleep-health intervention that leverages the science on habit formation. It will evaluate if adding a text messaging intervention improves habit formation. The participants will be 18-30 years old.
What is the current status of trial NCT05167695?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2022-05-04. Estimated completion is 2026-07-01.
What conditions does trial NCT05167695 study?
This clinical trial studies the following conditions: Circadian Dysregulation.
What interventions are being tested in trial NCT05167695?
The interventions under investigation include: Habit-based Sleep Health Intervention (BEHAVIORAL), Text messaging intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05167695?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05167695 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Circadian Dysregulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05167695's enrollment target sits among peer trials
160 2nd of 10 the highest of 10 other Circadian Dysregulation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Circadian Dysregulation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
RECRUITING · NA
-
Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)
RECRUITING · NA
-
Nighttime Synchrony of Your Nutrition and Circadian Health
RECRUITING · NA
-
Circadian Health Regulation and Optimization for Rejuvenation Outcomes
ACTIVE NOT RECRUITING · NA
-
A Pilot Test of Mood and Circadian Rhythm Mechanisms Driving Binge Eating
COMPLETED · NA
-
The Impact of Artificial Sunlight on Human Sleep and Circadian Rhythms
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI